Gilead's New CEO: 'It's Time For Us to Go Out and Do Important Deals'

Gilead Sciences' CEO John Milligan discusses growth strategies for the biotechnology firm. read more
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.